PPARs在心肌代谢性重塑中的作用
摘要
糖尿病和胰岛素抵抗被认为是高血压和冠心病等心血管事件的独立危险因素,该类患者具有较高心血管疾患的罹患率和致死率,且其心血管病变有独特的病理学和病理生理学特征,涉及包括细胞、细胞器的结构和功能异常、能量代谢的转换、基因表达的调节等诸多方面,对心脏结构和功能的改变至关重要.我们把此类患者的心血管重塑现象称为代谢性重塑(metabolic remodeling).
出处
《中国分子心脏病学杂志》
CAS
2003年第4期242-244,共3页
Molecular Cardiology of China
参考文献18
-
1[1]FORMAN BM CHEN J, EVANS RM. Hypolipidemic drugs,polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors αandγ, Proc Natl Acad Sei USA 1997; 94: 4312-4317
-
2[2]KLIEWER SA SUNDSETH SS,JONES SA,NROWN PJ WILISOTM, LENHARD JM. LEHMAN JM. Fatty acids and eicosanouds regulate gene expression through direct interactions with peroxisome proliferator-activated receptors αandγ. Proc Natl Acad Sci USA1997; 94:4318-4323
-
3[3]Rubler, s., et al. 1972. New type of cardiomyopathy asociated with glomerulosclerosis. Am. J. Cardiol. 30:595-602.
-
4[4]Stanley, W. C., Lopaschuk, G. D., and McCormack, J.G. 1977. Regulation If energy substrate metablism in the diabetic heart. Cardiovasc. Res. 34:25-33
-
5[5]Neely, J. R., Roveto, M. J., and Oram, J, F. 1972. Myocardial utilization If carbohydrate and lipids. Prog. Cardiovasc.Dis. 15: 289-329
-
6[6]Murthu, V. K., and Shipp. J. C. 1977. Accunulation of myocardial teiacylglycerols in ketotic diabetes. Diabetes.26 : 222-229.
-
7[7]FINCK B.; EHMAN JJ,LEONE TC,WEKCH MJ,BENNETT MJ,KOVACS A,HAN X,GRODD RW KOZAK R,LOPASCHUK GD,LELLY DP. The cardiac phenotype induced by diabetesmellitus,J Clin Invest 2002;109:121-130
-
8[8]Arber. S., Hunter. J. J., RossJr., J., Hongo, M., sandig,G., Borg. J., Perriard, J. C., Chien. K. R., Caroni. P., 1977.MLP-deficient mice exhibit a disruption of cardiac cutoarchitectural organization. dilated cardionyopathy, and heart failture.Cell88, 393-403
-
9[9]Murthu, V. K., and Shipp. J. C. 1977. Accunulation of myocardial teiacylglycerols in ketotic diabetes. Diabetes. 26 :222-229
-
10[10]T, Lemberger, B. Desvergbe, W. Wahli, Anny, Tev,CellDev. Biol. 12, 335 (1996)
-
1张靖澜,刘红燕,余劲明.糖尿病患者尿白蛋白与慢性血管并发症关系的探讨[J].广西医学,1999,21(5):868-869.
-
2董云,方玉才.2型糖尿病中老年患者血脂及载脂蛋白检测的临床意义[J].浙江预防医学,2003,15(5):70-70.
-
3马玉玲.糖尿病患者更要提防血管疾患[J].老年健康,2012(6):13-14.
-
4李秀明,顾美红.高频彩色多普勒超声对颈动脉粥样硬化诊断的临床价值[J].广西中医学院学报,2007,10(4):55-56.
-
5董德宏,王瑞玲.静脉溶栓疗法在乡镇卫生院应用体会[J].中国乡村医药,2003,10(2):11-12.
-
6赵晓春,许桂菊,冀秀芳.初诊2型糖尿病患者35例血浆纤维蛋白原观察[J].山西医药杂志（下半月）,2009,38(5):423-424. 被引量：3
-
7刘卫.肺动脉高压的诊断及治疗进展[J].中国医学文摘（内科学）,2006,27(2):130-131. 被引量：2
-
8齐加欣.护理 动脉硬化闭塞症的护理[J].山东卫生,2005(12):57-58.
-
9周琳,饶莉.过氧化物酶体增殖物激活受体-γ与冠心病炎性过程[J].西部医学,2008,20(1):188-190. 被引量：4
-
10仲琳,张运.罗格列酮——架起治疗冠心病与糖尿病的桥梁[J].中国循环杂志,2004,19(5):392-394.
